Significant progress has been made in the second generation COVID-19 vaccine against the Omicron mutant strain in China. The vaccine, by WestVac BioPharma Co. Ltd,belongs to the latest fifth generation vaccine technology, targeting the S-RBD protein of the COVID-19 mutant strain.   The large-scale production of vaccines adopts internationally advanced insect cell production technology and … Continue reading COVID-19 Vaccine Developed has high neutralising Antibodies Against Omicron